Belgian IBD Research and Development
- Address
- Leuvensesteenweg 643
Sponsor Overview
Specializations
Crohn's disease
Clinical research in Crohn's disease is centred on patients with ongoing inflammatory activity and previous treatment loss of response, with attention to maintaining control over gastrointestinal inflammation and mucosal disease activity.
- Long-term disease control
- Biologic treatment optimisation
- Loss of response management
Work in this area includes interest in sustained outcomes with biologic therapy and treatment adjustments in patients with persistent inflammatory bowel disease.
Ulcerative colitis and unclassified inflammatory bowel disease
Research activity also extends to ulcerative colitis and inflammatory bowel disease type unclassified, reflecting a broader focus on chronic intestinal inflammation and related clinical outcomes across IBD subtypes.
- Inflammatory bowel disease subtypes
- Clinical remission maintenance
- Biological disease monitoring
The sponsor's trial portfolio includes comparisons relevant to patients whose disease course requires ongoing assessment of symptom control and biological response.
Biologic therapy optimisation
The funded studies focus on optimisation of established monoclonal antibody treatments, with interest in how changes in administration schedules affect clinical efficacy and biological outcomes.
- Ustekinumab
- Infliximab
- Subcutaneous maintenance therapy
This area highlights continued evaluation of advanced therapeutics used in chronic immune-mediated bowel disease.
Clinical and biological remission
Another key interest is the preservation of clinical remission alongside biological remission, with research examining how patients respond after switching between intravenous and subcutaneous treatment approaches.
- Remission maintenance
- Treatment switching
- Outcome comparison
These studies address practical questions in the management of chronic inflammatory bowel disorders within specialist care settings.
Sponsored Trials
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 22 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases2 trials280 other sponsors
Partnered Research Centres
22 centres- Address
- Gouwelozestraat 100, 8400 Ostend
- Address
- Deltalaan 1, 8800 Roeselare
- Address
- Buitenring-Sint-Denijs 30, 9000 Ghent
- Address
- Groenebriel 1, 9000 Ghent
- Address
- Ruddershove 10, 8000 Bruges
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Belgian IBD Research and Development.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.